The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis - Results from the multiple outcomes of raloxifene evaluation study

被引:0
|
作者
Silverman, SL
Minshall, ME
Shen, W
Harper, KD
Xie, S
机构
[1] OMC Clin Res Ctr, Beverly Hills, CA 90211 USA
[2] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Greater Los Angeles VA Hlth Syst, Los Angeles, CA 90048 USA
[3] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 11期
关键词
D O I
10.1002/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine the effect of both Prevalent and incident vertebral fractures on health-related quality of life (HRQOL) in postmenopausal women with osteoporosis and to characterize the effect of prevalent vertebral fractures on HRQOL with respect to number, location, severity, and adjacency. Methods. Participants were a subset of women (n = 1,395, mean age 68.5 years) from the Multiple Outcomes of Raloxifene Evaluation trial who had low bone mineral density and/or prevalent vertebral fractures. Vertebral fractures were measured by radiography at baseline, 2 years, and 3 years. HRQOL was assessed using the Osteoporosis Assessment Questionnaire (OPAQ), a validated disease-targeted instrument, at baseline and annually for 3 years. Results. Both prevalent and incident radiographic vertebral fractures were associated with decreased HRQOL. At baseline, women with a prevalent vertebral fracture had significantly lower OPAQ scores on physical function, emotional status, clinical symptoms, and overall HRQOL compared with women without a prevalent fracture (all P < 0.01). HRQOL scores were lower with each subsequent fracture. The effect of prevalent vertebral fracture was dependent on the location within the spine and was strongest in the lumbar region (L1-L4). Incident vertebral fractures significantly decreased OPAQ scores on physical function, emotional status, clinical symptoms, and overall HRQOL (all P < 0.001). Conclusion. Our findings demonstrate the importance of treating postmenopausal women who have prevalent vertebral fractures to prevent further decreases in HRQOL associated with subsequent incident vertebral fracture.
引用
收藏
页码:2611 / 2619
页数:9
相关论文
共 50 条
  • [31] VITAMIN D STATUS AND ITS RELATIONSHIP WITH HEALTH-RELATED QUALITY OF LIFE IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN WITH AND WITHOUT (NON) VERTEBRAL FRACTURES
    Grbovic, V.
    Skevin, A. Jurisic
    Lucic, A. Tomic
    Ilic, K. Parezanovic
    Veselinovic, M.
    Djordjevic, D.
    Pavlovic, D.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S82 - S82
  • [32] Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial
    Kanis, JA
    Johnell, O
    Black, DM
    Downs, RW
    Sarkar, S
    Fuerst, T
    Secrest, RJ
    Pavo, I
    BONE, 2003, 33 (03) : 293 - 300
  • [33] Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis: 4-year results from the MORE trial
    Pols, H
    Eastell, R
    Delmas, P
    Adachi, J
    Ensrud, K
    Harper, K
    Sarkar, S
    Gennari, C
    Reginster, JY
    Recker, R
    Harris, S
    Wu, W
    Black, D
    Genant, H
    BONE, 2001, 28 (05) : S85 - S86
  • [34] EVALUATION OF HEALTH-RELATED QUALITY OF LIFE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WHO PARTICIPATED IN THE FREEDOM TRIAL
    Silverman, S.
    Viswanathan, H.
    Wang, A.
    Ragi-Eis, S.
    Fardellone, P.
    Gilchrist, N.
    Lips, P.
    Nevitt, M.
    Palacios, S.
    Pavelka, K.
    Revicki, D.
    Simon, J.
    Macarios, D.
    Siris, E.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 14 - 15
  • [35] Effects of raloxifene on the severity of new vertebral fractures in postmenopausal women with osteoporosis: Results from the MORE trial.
    Siris, E
    Crans, G
    Sarkar, S
    Wong, M
    Harper, KD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S291 - S291
  • [36] Three years of health related quality of life assessment in postmenopausal women with osteoporosis: Impact of incident vertebral fractures, age and severe adverse events.
    Oleksik, AM
    Ewing, SK
    Duong, T
    Shen, W
    Lips, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S168 - S168
  • [37] The impact of incident vertebral and non-vertebral fractures on health related quality of life (HRQOL) in established postmenopausal osteoporosis: Results from the rhPTH(1-34) randomized, placebo-controlled trial in postmenopausal women.
    Minshall, ME
    Silverman, SL
    Shen, W
    Xie, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S541 - S541
  • [38] Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women
    Palacios, S.
    Neyro, J. L.
    Fernandez de Cabo, S.
    Chaves, J.
    Rejas, J.
    CLIMACTERIC, 2014, 17 (01) : 60 - 70
  • [39] Treatment with raloxifene reduces the incidence of new vertebral fractures in postmenopausal women with prevalent nonvertebral baseline fractures: Results from the more trial
    Fardellone, P
    Cohen-Solal, M
    Sarkar, S
    Pinette, K
    Liu-Leage, S
    Seeman, E
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S21 - S22
  • [40] Thoracic Kyphosis Index as a Risk Factor for Incident Vertebral Fractures with and Alteration of Quality of Life in Postmenopausal Women Osteoporosis
    Roux, C.
    Briot, K.
    Kolta, S.
    Said-Nahal, R.
    Benhamou, C.
    Fechtenbaum, J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S38 - S38